Key result
A non-blended metacognitive therapy web application demonstrated good feasibility and acceptability in cardiovascular disease patients, achieving a 91.2% learning module completion rate and significantly reducing anxiety.
Why the study?
Psychocardiological treatment options for mental disorders like anxiety and depression in cardiovascular disease patients are limited, creating a need to evaluate the feasibility of translating a face-to-face metacognitive therapy approach into a digital application.
Is a brief metacognitive therapy-based web application feasible and does it improve mental well-being and reduce anxiety in patients with cardiovascular disease?
Observational (n=18)
No
Is a brief metacognitive therapy-based web application feasible and does it improve mental well-being and reduce anxiety in patients with cardiovascular disease?
A brief, non-blended metacognitive therapy web application is feasible and may improve perceived health and reduce anxiety in patients with cardiovascular disease.
Supports integrating brief MCT into CVD care for anxiety/depression; first RCT extends promising prior findings.
Background: Many patients with cardiovascular disease also show a high comorbidity of mental disorders, especially such as anxiety and depression. This is, in turn, associated with a decrease in the quality of life. Psychocardiological treatment options are currently limited. Hence, there is a need for novel and accessible psychological help. Recently, we demonstrated that a brief face-to-face metacognitive therapy (MCT) based intervention is promising in treating anxiety and depression. Here, we aim to translate the face-to-face approach into digital application and explore the feasibility of this approach. Methods: We translated a validated brief psychocardiological intervention into a novel non-blended web app. The data of 18 patients suffering from various cardiac conditions but without diagnosed mental illness were analyzed after using the web app over a two-week period in a feasibility trial. The aim was whether a non-blended web app based MCT approach is feasible in the group of cardiovascular patients with cardiovascular disease. Results: Overall, patients were able to use the web app and rated it as satisfactory and beneficial. In addition, there was first indication that using the app improved the cardiac patients' subjectively perceived health and reduced their anxiety. Therefore, the approach seems feasible for a future randomized controlled trial. Conclusion: Applying a metacognitive-based brief intervention via a non-blended web app seems to show good acceptance and feasibility in a small target group of patients with CVD. Future studies should further develop, improve and validate digital psychotherapy approaches, especially in patient groups with a lack of access to standard psychotherapeutic care.
No takes yet. Share an insight, caveat, or question.
Larionov et al. (2023) conducted an observational in Cardiovascular disease (n=18). Non-blended metacognitive therapy web application was evaluated on Feasibility (learning module completion rate). A non-blended metacognitive therapy web application demonstrated good feasibility and acceptability in cardiovascular disease patients, achieving a 91.2% learning module completion rate and significantly reducing anxiety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: